key: cord-1000033-ju9fjyuf authors: nan title: MMWR summary: COVID‐19 reports date: 2020-05-29 journal: Am J Transplant DOI: 10.1111/ajt.15991 sha: cb64a9ad11ea1e1a7899e4b2c49709df68398621 doc_id: 1000033 cord_uid: ju9fjyuf This month’s MMWR selections summarize several recent observations related to COVID‐19 infection. This month's MMWR selections summarize several recent observations related to SARS-Cov2-19 infection . At this time, COVID-19 has been reported from all 50 states and in a single week in early April, the case rate was observed to increase significantly throughout the majority of states, especially in the Northeastern US and Louisiana. 1 In the month of March, hospitalization rates were 4.6 per 100 000 population, with the highest rates occurring in those ≥65 years of age. 2 Approximately 90% of hospitalized patients had at least one comorbid condition, including obesity, hypertension, diabetes mellitus, and/or cardiovascular or chronic lung disease. Notably, early reports from New York City, New Orleans, Seattle, and San Francisco suggest that community mitigation measures, including social distancing and reduction of community mobility, may reduce the spread of infection. 2 Healthcare personnel are at increased risk for COVID-19 acquisition, related to both work situations following exposure to both patients and other healthcare providers as well as community exposure. 3 Cases have been more commonly reported in women than men, likely reflecting the greater numbers of women working as healthcare providers. Importantly, a risk factor for acquisition in the healthcare setting has been exposure to patients with unrecognized COVID-19, especially if the exposure was prolonged or occurred during an aerosol generating procedure. 4 Geographic differences in COVID-19 cases, deaths, and incidence -United States Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 states Timing of community mitigation and changes in reported COVID-19 and community mobility -four U.S. metropolitan areas Characteristics of health care personnel with COVID-19 -United States Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient